[EN] DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS<br/>[FR] DIHYDROPYRIDAZINONES SUBSTITUÉES PAR DES PHÉNYLURÉES
申请人:BAYER PHARMA AG
公开号:WO2018086703A1
公开(公告)日:2018-05-17
Compounds of formula (I) which are nicotinamide phosphoribosyltransferase (NAMPT) inhibitors and their use for the treatment of hyperproloferative diseases and/or disorders responsive to induction of cell death.
式(I)的化合物是烟酰胺磷酸核糖转移酶(NAMPT)抑制剂,可用于治疗对诱导细胞死亡敏感的增生性疾病和/或紊乱。